Back to Search Start Over

ALS2-Related Motor Neuron Diseases: From Symptoms to Molecules.

Authors :
Miceli, Marcello
Exertier, Cécile
Cavaglià, Marco
Gugole, Elena
Boccardo, Marta
Casaluci, Rossana Rita
Ceccarelli, Noemi
De Maio, Alessandra
Vallone, Beatrice
Deriu, Marco A.
Source :
Biology (2079-7737); Jan2022, Vol. 11 Issue 1, p77-77, 1p
Publication Year :
2022

Abstract

Simple Summary: Mutations of the ALS2 gene, which encodes for the protein Alsin, are linked to three recessive motor neuron diseases characterized by early onset. Alsin is an intriguing protein characterized by several structured domains with distinct functions. To date, it is not fully understood how the aforementioned domains collaborate in the development of Alsin functions and how mutations, located in specific areas of these domains, correlate with Alsin malfunction and disease onset. This study collects information from the literature rationalized on three levels of investigation: a systemic scale (symptoms of the pathology), a protein scale (molecular phenomena that drive the development of the pathology) and a population scale (comparison between ALS2-related diseases and detected mutations). Differences and similarities among ALS2-related diseases are comprehensively highlighted here and correlated with Alsin mutations. Infantile-onset Ascending Hereditary Spastic Paralysis, Juvenile Primary Lateral Sclerosis and Juvenile Amyotrophic Lateral Sclerosis are all motor neuron diseases related to mutations on the ALS2 gene, encoding for a 1657 amino acids protein named Alsin. This ~185 kDa multi-domain protein is ubiquitously expressed in various human tissues, mostly in the brain and the spinal cord. Several investigations have indicated how mutations within Alsin's structured domains may be responsible for the alteration of Alsin's native oligomerization state or Alsin's propensity to interact with protein partners. In this review paper, we propose a description of differences and similarities characterizing the above-mentioned ALS2-related rare neurodegenerative disorders, pointing attention to the effects of ALS2 mutation from molecule to organ and at the system level. Known cases were collected through a literature review and rationalized to deeply elucidate the neurodegenerative clinical outcomes as consequences of ALS2 mutations. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20797737
Volume :
11
Issue :
1
Database :
Complementary Index
Journal :
Biology (2079-7737)
Publication Type :
Academic Journal
Accession number :
154805973
Full Text :
https://doi.org/10.3390/biology11010077